As per DelveInsight’s assessment, the Vascular Stents Devices Market is expected to grow at an immense pace in the coming years owing to the rising incidence of Cardiovascular Diseases which is expected to drive the demand for Vascular Stents Devices in the upcoming years.
DelveInsight’s “Vascular Stents Devices Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Vascular Stents Devices companies actively working in the market.
Vascular Stents Devices
Vascular stents have been widely employed by cardiac surgeons for a number of years and are significant medical devices in the treatment of a number of circulatory problems. However, they are linked to a number of issues that affect the body’s capacity to accommodate them.
Vascular Stents Devices Market Insights
Geographically, the global Vascular Stents Devices market is studied in North America, Europe, Asia-Pacific, and the Rest of the World. During the forecast period, North America is anticipated to hold a significant market share for vascular stents. This is due to the increased rates of obesity, hypertension, alcohol consumption, and smoking, which frequently result in a variety of cardiovascular disorders such coronary heart disease and peripheral vascular diseases that call for vascular stenting as a treatment. The need for vascular stents has also increased as a result of the region’s aging population, rapid technological breakthroughs, and rising healthcare costs.
To know more about why North America is leading the market growth in the Vascular Stents Devices market, get a snapshot of the report Vascular Stents Devices Market Trends
Recent Developments in the Vascular Stents Devices Market Report
- In August 2020, Boston Scientific Corporation received FDA approval for SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail™), SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System (Over-The-Wire™), and SYNERGY™ XD Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail™) is indicated for use in patients who have a narrowing in their coronary arteries and are at high risk for bleeding.
- In July 2020, INSPIRON Coronary Sirolimus-Eluting Stent from SCITECH Medical received CE Mark approval.
- In May 2020, SMT (Sahajanand Medical Technologies Pvt. Ltd) acquired the structural heart medical device firm Vascular Concepts, providing cutting-edge medical devices for the treatment of arterial diseases.
- Thus, owing to such developments in the market, rapid growth will be observed in the Vascular Stents Devices market during the forecast period
To read more about the latest highlights related to Vascular Stents Devices, get a snapshot of the key highlights entailed in the Vascular Stents Devices
Key Players in the Vascular Stents Devices Market
Some of the key market players operating in the Vascular Stents Devices market include- Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, and others.
COVID-19 Impact Analysis on the Vascular Stents Devices Market
The Global Vascular Stents Devices market is witnessing growth due to the rise in the use of Vascular Stents Devices in various applications. The rising incidence of vascular disorders such atherosclerosis, carotid artery illnesses, and peripheral artery diseases, among others, is the main cause fueling the demand for vascular stents. Additionally, increasing patient preferences for minimally invasive procedures, escalating product technological advancement, and the approval of various vascular stents, among other things, are some of the factors expected to propel the worldwide vascular stents market in the years to come.
Additionally, The initial effects of the exceptional COVID-19 outbreak have delayed the global market for Vascular Stents. Several factors contribute to the slow market growth of vascular stents, including the nationwide lockdown, the cancellation or denial of elective surgeries to stop the spread of the virus, and the disruption of the supply chain owing to logistical restrictions across the border. However, a significant improvement in the resumption of activities across various domains, including healthcare services, was seen in the second half of 2020 thanks to the approval and administration of numerous COVID-19 vaccines around the world. This paved the way for a sound period of recovery for the vascular stents market.
Scope of the Vascular Stents Devices Market Report
- Coverage: Global
- Study Period: 2019–2027
- Vascular Stents Devices Market Segmentation By Product Type: (Ventricular Assist Devices (VADs) [LVAD, RVAD, BiVAD], Implantable Cardioverter Defibrillators [Transvenous ICD, Subcutaneous ICD], Pacemakers [Implantable, External], Cardiac Resynchronization therapy [Cardiac Resynchronization Therapy-Defibrillators (CRT-D), Cardiac Resynchronization Therapy-Pacemakers (CRT-P)], , and others
- Vascular Stents Devices Market Segmentation By End-User: (Hospitals And Clinics, Ambulatory Surgical Centers, Others), and others
- Vascular Stents Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Vascular Stents Devices Companies: Medtronic (MDT), Abbott (ABT), Boston Scientific Corporation (BSX), BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation (4543), eucatech AG, MicroPort Scientific Corporation. (0853), Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton Dickinson and Company (BDX), ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, among others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
DelveInsight Analysis: The Global Vascular Stents Devices market was valued at USD 13.31 billion in the year 2021 and is anticipated to grow with a CAGR of 7.90% during the forecasted period (2022-2027)
Which MedTech key players in the Vascular Stents Devices market are set to emerge as the trendsetter explore @ Vascular Stents Devices
Table of Contents
| 1 | Vascular Stents Devices Market Report Introduction |
| 2 | Vascular Stents Devices Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Vascular Stents Devices Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Vascular Stents Devices Market |
| 7 | Vascular Stents Devices Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11. | About DelveInsight |
Interested in knowing how the Vascular Stents Devices market will grow by 2027? Click to get a snapshot of the Vascular Stents Devices Market Analysis
Related Reports
Related Reports By DelveInsight –
DelveInsight’s “Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight’s “Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight’s “Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
22q11.2 deletion syndrome Market
DelveInsight’s “22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
X-Linked Retinitis Pigmentosa (XLRP) Market
DelveInsight’s “X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Other Trending Reports
Hypertrophic Scar Market | Lung Fibrosis Market | Anterior Uveitis Market | 22q11.2 deletion syndrome Market | X-Linked Retinitis Pigmentosa (XLRP) Market | Acute Radiation Syndrome Market | Alpha-1 Protease Inhibitor Deficiency Market | Androgenetic Alopecia Market | Hyperlipidemia Market | Cardiotoxicity Market | Hypertrophic Cardiomyopathy Market | Fatty Acid Oxidation Disorders (FAODs) Market | Androgen Insensitivity Syndrome Market | Emphysema Market | Canaloplasty Market | Dravet Syndrome Market | Celiac Disease Market | Chlamydia Infections Market | Syphilis Market | Renal Tubular Acidosis Market | Palmoplantar Pustulosis (PPP) Market | Aplastic Anemia Market | Bacterial Pneumonia Market | B cell Chronic Lymphocytic Leukemia Market | B cell Lymphomas Market | Behcets Disease Market Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast—by 2035 | Glioblastoma Market
Latest Healthcare Blogs
Recent Blog’s By DelveInsight:
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Gaurav Bora
info@delveinsight.com
+1(919)321-6187